Financial News

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

by
News PRO
November 5, 2025

Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.Read More

Related

Related Topics

More in Financial News

Toyota profits fall for a second consecutive quarter, missing estimates, as U.S. tariffs hit exports

Post ContentRead More
California voters pass Prop 50 to redraw the state’s congressional maps, CBS News projects

California voters have passed Proposition 50, CBS News projects, approving a measure backed by...
Democrats win big on Election Night in key races

President Donald Trump said that the reason that Republicans lost big was because he...
SoftBank wipes out about $32 billion in market cap as Asian AI stocks slide on valuation jitters

The frenzy around AI has sparked concerns that markets could be in the midst...

Toyota profits fall for a second consecutive quarter, missing estimates, as U.S. tariffs hit exports